tirzepatide trials on ingestive behavior in adults with overweight or obesity: a randomized 6-week phase 1 trial Tirzepatide once weekly for the

These medications help control blood sugar levels by mimicking the action of a hormone called GLP-1 (glucagon-like peptide-1), which increases insulin release and decreases the amount of sugar produced by the liver

Mitchell, J

The American Association for the Study of Liver Diseases (AASLD) acknowledges the potential role of GLP-1 receptor agonists in managing MASLD, particularly in patients with concurrent type 2 diabetes or obesity

That includes the anti-inflammatory effect, the ability to reduce cell death and promote autophagy, and also its indirect effects through blood pressure, obesity, and glucose/lipid metabolism